Results 71 to 80 of about 56,324 (305)

Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature [PDF]

open access: yes, 2019
Langerhans cell histiocytosis (LCH) is a diagnostic and therapeutic challenge. We report on a rare case of its primary oral manifestation that was treated successfully with the BRAF-specific agent, vemurafenib, after insufficient standard LCH treatment ...
Beck-Broichsitter, Benedicta   +8 more
core   +1 more source

Lamotrigine and anti‐seizure medications in HLH: A systematic review

open access: yesBritish Journal of Haematology, EarlyView.
Lamotrigine and other anti‐seizure medications have been reported to cause both haemophagocytic lympho‐histiocytosis (HLH) and drug‐induced hypersensitivity syndrome (DIHS). HLH and DIHS have many characteristic clinical, laboratory, pathological findings and underlying mechanisms; we identified significant clinical overlap between these two syndromes ...
Yaswanta K. Gummadi   +4 more
wiley   +1 more source

Diagnosis, treatment and recurrence of a mandibular Langerhans cell histiocytosis: a three-year follow-up case report

open access: yesJournal of Oral Medicine and Oral Surgery, 2022
Introduction: Langerhans cell histiocytosis (LCH) is an abnormal clonal proliferation of Langerhans cells secondary to immune process, mutation of oncogene or genetic predispositions. It preferentially affects bone, lung and skin.
Morcel Marion   +5 more
doaj   +1 more source

Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective This study investigated the prevalence, characteristics, and endocrine implications of thyroid incidentalomas detected during lymphoma staging using FDG‐PET/CT. Design Retrospective cohort study. Patients A total of 795 adult patients with lymphoma who underwent FDG‐PET/CT for staging at a tertiary oncology centre were included ...
Marcos Tadashi Kakitani Toyoshima   +10 more
wiley   +1 more source

A Case of Orbital Langerhans Cell Histiocytosis in an Adult

open access: yesActa Médica Portuguesa, 2019
Langerhans cell histiocytosis remains an enigmatic disease with a very heterogeneous presentation. We describe a rare case of orbital Langerhans cell histiocytosis in a 39-year-old female patient who presented right orbital pain and edema of the upper ...
Inês Carneiro   +2 more
doaj   +1 more source

Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil [PDF]

open access: yes, 2013
Background: Paraneoplastic cerebellar degeneration (PCD) is a classical tumor-associated, immune-mediated disease typically associated with gynecological malignancies, small-cell lung-cancer or lymphoma.
Hartmann, Sylvia   +5 more
core   +1 more source

An Unusual Case of Cutaneous Langerhans Cell Sarcoma Lacking S100 Expression: A Case Report and Review of the Literature

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Langerhans cell sarcoma (LCS) is a rare neoplastic proliferation of Langerhans cell with aggressive clinical behavior and involves multiple organ systems, including the skin. LCS is characterized by marked cytologic atypia, frequent mitoses including atypical ones, and expression of CD1a, S100, and langerin (CD207).
Randa Obid   +8 more
wiley   +1 more source

Rosai‐Dorfman disease presenting with solitary liver mass without lymphadenopathy: A case report

open access: yesClinical Case Reports, 2021
Rosai‐Dorfman disease (RDD), as a lymphoproliferative disorder with unknown etiology, is commonly identified with systemic clinical manifestations in various organs. In this case study, RDD occurrence was reported with an exceedingly liver mass.
Yousef Roosta   +9 more
doaj   +1 more source

Sinus Histiocytosis: An Uncommon Presentation of an Uncommon Condition [PDF]

open access: yes, 2015
Introduction Rosai–Dorfman Disease (RDD), also known as Sinus Histiocytosis with Massive Lymphadenopathy (SHML), is a rare, benign, proliferative disorder of macrophages and monocytes that was first described by Rosai and Dorfman in 1969.
Greco, MD, Allison, Kane, MD, Gregory
core   +2 more sources

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

open access: yesBlood, 2016
Langerhans cell histiocytosis (LCH) is characterized by inflammatory lesions containing pathologic CD207+ dendritic cells with constitutively activated ERK.
Rikhia Chakraborty   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy